Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2

European Journal of Biochemistry

Volumn 268, Issue 21, 2001, Pages 5530-5540

  Kirkin, Vladimir ^a   Mazitschek, Ralph ^b   Krishnan, Jaya ^a   Steffen, Anja ^a   Waltenberger, Johannes ^c   Pepper, Michael S ^d   Giannis, Athanassios ^b   Sleeman, Jonathan P ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Inhibitors; Lymphangiogenesis; VEGF C; VEGF D; VEGFR 3

Indexed keywords

INDOLE DERIVATIVE; MUTANT PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0035719850     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2001.02476.x     Document Type: Article

References (43)

1. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan
2. Limbal lymphangiogenesis after corneal injury: An autoradiographic study
3. Proliferation of lymphatics in inflammation
4. Lymphatic regeneration following microvascular limb replantation: A qualitative and quantitative animal study
5. Signaling angiogenesis and lymphangiogenesis
6. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
7. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
8. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
9. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
10. Characterization of murine Flt4 ligand/VEGF-C
11. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
12. Proteolytic processing regulates receptor specificity and activity of VEGF-C
13. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
14. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
15. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangio-genesis in the differentiated avian chorioallantoic membrane
16. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
17. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
18. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
19. Vascular endothelial growth factor C induces angiogenesis in vivo
20. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
21. c-Fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
22. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
23. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
24. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
25. Lymphangiogenesis and tumor metastasis: Myth or reality?
26. Hereditary lymphedema: Evidence for linkage and genetic heterogeneity
27. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase
28. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
29. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
30. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution
31. Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein
32. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44
33. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
34. Xenopus A-myb is expressed during early spermatogenesis
35. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities
36. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells
37. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
38. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases
39. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
40. Vascular endothelial growth factor receptor-3
41. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
42. Stage T1A carcinoma of prostate